Case Overview

The Parties

Patents at Issue

Seven U.S. patents formed the foundation of this infringement action, collectively covering the chemistry, formulation, and application methodology of interior beverage-can spray coatings:

• • US7,592,047 (App. No. 11/253161)
• • US8,092,876 (App. No. 12/505236)
• • US8,617,663 (App. No. 13/412236)
• • US8,835,012 (App. No. 13/801133)
• • US9,242,763 (App. No. 14/453280)
• • US9,415,900 (App. No. 14/918258)
• • US9,862,854 (App. No. 15/205490)

The breadth of the portfolio, spanning multiple application numbers and filing generations, reflects a deliberate **continuation-based prosecution strategy** designed to create layered, durable patent protection.

Accused Product

The accused product, **INNOVEL HPS beverage-can spray coatings**, is an interior can lining technology relevant to food-contact and beverage packaging safety. Its commercial significance in the BPA-free coatings transition makes it a high-value target for patent protection and, correspondingly, litigation.

Legal Representation

Sherwin-Williams and PPG were represented by **Jones Day**, with attorneys **Gregory A. Castanias**, **Jennifer L. Swize**, and **Joseph Farley** leading the appellate team. Castanias is a recognized Federal Circuit appellate practitioner, lending significant credibility to the litigation strategy. Defendant counsel information was not available in the public case record.

The Verdict & Legal Analysis

Outcome

The Federal Circuit **affirmed** the prior infringement ruling and **dismissed the appeal**, leaving intact the finding that the INNOVEL HPS beverage-can spray coatings infringed one or more claims across the asserted patent portfolio. Specific damages figures were not disclosed in the available case record. Injunctive relief details similarly were not publicly available at the time of this publication.

Verdict Cause Analysis

The verdict cause is classified as an **Infringement Action**, affirmed on appeal. While the complete judicial opinion details were not available for granular claim-by-claim analysis, several procedurally significant observations can be drawn:

Claim Construction Durability: With seven patents at issue, the appellate court’s affirmation strongly suggests the trial court’s claim construction survived de novo Federal Circuit review—a notoriously rigorous standard. Plaintiffs’ prosecution strategy, building a generational portfolio from application numbers spanning 2005 (US11/253161) through 2016 (US15/205490), likely created claim coverage broad enough to capture the accused product across multiple technical dimensions.

Portfolio Depth as a Litigation Advantage: The staggered filing dates across the seven patents indicate a **continuation prosecution strategy**—filing successive continuation applications to pursue claims of varying scope. This approach is particularly effective in litigation because it creates redundancy: even if some claims are invalidated or construed narrowly, others remain to support infringement findings. The Federal Circuit’s affirmation validates this multi-patent assertion strategy.

Appellate Dismissal Significance: An appeal dismissed with affirmation—rather than a substantive reversal or remand—signals the Federal Circuit found the appellant’s arguments insufficient to meet the high bar for reversing factual findings or de novo claim construction. This is a complete defense win for the patent holders at the appellate stage.

Legal Significance

This outcome reinforces several important principles in **specialty coatings patent litigation**:

• Continuation portfolio strategies provide enforceable redundancy in multi-patent assertions.
• The Federal Circuit continues to show deference to well-supported trial court findings in technically complex infringement cases.
• Co-plaintiff structures between market competitors (Sherwin-Williams and PPG) are viable when parties share overlapping IP interests against a common accused infringer.

Strategic Takeaways

For Patent Holders: Build continuation portfolios with claims of varying scope to ensure infringement coverage survives post-grant challenges and appellate claim construction review. Co-ownership or co-plaintiff structures can pool litigation resources against shared competitive threats.

For Accused Infringers: When facing multi-patent portfolios spanning a decade of prosecution, early **inter partes review (IPR)** petitions at the USPTO—challenging validity before or during district court proceedings—can be critical. A successful IPR can moot infringement claims before reaching the Federal Circuit.

For R&D Teams: Products operating in technically adjacent spaces to patented coating formulations require rigorous **Freedom to Operate (FTO) analyses** covering not just issued patents but published applications within active continuation families. The INNOVEL HPS dispute illustrates how a single product can infringe across seven distinct patents simultaneously.

Industry & Competitive Implications

The beverage-can interior coating market has been in active transition for over a decade, driven by regulatory pressure to eliminate **bisphenol A (BPA)** from food-contact coatings. Technologies like INNOVEL HPS occupy a commercially valuable position as BPA-free alternatives, making their IP protection commercially critical and litigation-worthy.

The Sherwin-Williams and PPG co-plaintiff alignment is strategically significant: two competitors temporarily uniting their IP interests against a common accused product reflects how dominant players in a market segment can coordinate to protect foundational technology from competitive entry.

For companies developing next-generation interior can coatings, food-contact packaging technologies, or BPA-free spray applications, this Federal Circuit affirmation signals that **Sherwin-Williams and PPG’s seven-patent portfolio remains fully enforceable**. Licensing negotiations in this space should now account for the appellate-validated strength of these patents.

The case also reflects a broader litigation trend: **multi-patent portfolio assertions** in specialty materials and coatings are increasing as formulators seek to protect years of R&D investment in regulatory-compliant chemistries.